Cited by 32

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Rapid lentiviral transduction preserves the engraftment potential of Fanca(−/−) hematopoietic stem cells

Müller, Lars UW, Milsom, Michael D, Kim, Mi-Ok, Schambach, Axel, Schuesler, Todd, Williams, David A·2008·Molecular Therapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2008.67

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 45

  1. Taniguchi, 2006, Molecular pathogenesis of Fanconi anemia: recent progress, Blood, 107, 4223, 10.1182/blood-2005-10-4240 · DOI
  2. Smogorzewska, 2007, Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair, Cell, 129, 289, 10.1016/j.cell.2007.03.009 · DOI
  3. Kutler, 2003, A 20-year perspective on the International Fanconi Anemia Registry (IFAR), Blood, 101, 1249, 10.1182/blood-2002-07-2170 · DOI · Paper page
  4. Rosenberg, 2005, Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants, Blood, 105, 67, 10.1182/blood-2004-04-1652 · DOI
  5. Farzin, 2007, Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience, Br J Haematol, 136, 633, 10.1111/j.1365-2141.2006.06460.x · DOI · Paper page
  6. Wagner, 2007, Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia, Blood, 109, 2256, 10.1182/blood-2006-07-036657 · DOI · Paper page
  7. Liu, 1997, Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients, Hum Gene Ther, 8, 1715, 10.1089/hum.1997.8.14-1715 · DOI
  8. Yamada, 2003, Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector, Mol Ther, 8, 600, 10.1016/S1525-0016(03)00223-5 · DOI · Paper page
  9. Galimi, 2002, Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors, Blood, 100, 2732, 10.1182/blood-2002-04-1245 · DOI · Paper page
  10. Rio, 2002, In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice, Blood, 100, 2032, 10.1182/blood.V100.6.2032 · DOI
  11. Liu, 1999, Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC), Hum Gene Ther, 10, 2337, 10.1089/10430349950016988 · DOI · Paper page
  12. Li, 2005, Ex vivo culture of Fancc−/− stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy, Blood, 105, 3465, 10.1182/blood-2004-06-2483 · DOI · Paper page
  13. Miller, 1990, Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection, Mol Cell Biol, 10, 4239, 10.1128/MCB.10.8.4239 · DOI · Paper page
  14. Reiser, 1996, Transduction of nondividing cells using pseudotyped defective high- titer HIV type 1 particles, Proc Natl Acad Sci USA, 93, 15266, 10.1073/pnas.93.26.15266 · DOI · Paper page
  15. Kurre, 2006, Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells, Gene Ther, 13, 369, 10.1038/sj.gt.3302659 · DOI
  16. Mostoslavsky, 2005, Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation, Mol Ther, 11, 932, 10.1016/j.ymthe.2005.01.005 · DOI
  17. Cheng, 2000, Mice with a targeted disruption of the Fanconi anemia homolog Fanca, Hum Mol Genet, 9, 1805, 10.1093/hmg/9.12.1805 · DOI · Paper page
  18. Haneline, 1999, Loss of FancC function results in decreased hematopoietic stem cell repopulating ability, Blood, 94, 1, 10.1182/blood.V94.1.1.413k03_1_8 · DOI
  19. Navarro, 2006, Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1, Mol Ther, 14, 525, 10.1016/j.ymthe.2006.05.018 · DOI
  20. Xu-Welliver, 1998, Isolation of human O6-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by O6-benzylguanine, Cancer Res, 58, 1936
  21. Zielske, 2003, In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning, J Clin Invest, 112, 1561, 10.1172/JCI200317922 · DOI
  22. Sawai, 2001, Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector, Mol Ther, 3, 78, 10.1006/mthe.2000.0223 · DOI
  23. Ragg, 2000, Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells, Cancer Res, 60, 5187
  24. Milsom, 2007, Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection, DNA Repair (Amst), 6, 1210, 10.1016/j.dnarep.2007.03.020 · DOI
  25. Chandra, 2005, A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients, Mol Ther, 12, 976, 10.1016/j.ymthe.2005.04.021 · DOI
  26. Gross, 2002, Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction, Cytogenet Genome Res, 98, 126, 10.1159/000069805 · DOI · Paper page
  27. Gregory, 2001, Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells, Proc Natl Acad Sci USA, 98, 2532, 10.1073/pnas.051609898 · DOI
  28. Freie, 1996, Correction of Fanconi anemia type C phenotypic abnormalities using a clinically suitable retroviral vector infection protocol, Cell Transplant, 5, 385, 10.1016/0963-6897(95)02022-5 · DOI
  29. Haneline, 2003, Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc−/− hematopoietic stem cells and decreases the risk of clonal evolution, Blood, 101, 1299, 10.1182/blood-2002-08-2404 · DOI
  30. Cavazzana-Calvo, 2000, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Science, 288, 669, 10.1126/science.288.5466.669 · DOI · Paper page
  31. Gaspar, 2004, Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped γ-retroviral vector, Lancet, 364, 2181, 10.1016/S0140-6736(04)17590-9 · DOI
  32. Aiuti, 2002, Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning, Science, 296, 2410, 10.1126/science.1070104 · DOI · Paper page
  33. Neff, 2005, Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy, Blood, 105, 997, 10.1182/blood-2004-08-3169 · DOI
  34. Li, 2004, Continuous in vivo infusion of interferon-γ (IFN-γ) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc−/− mice, Blood, 104, 1204, 10.1182/blood-2004-03-1094 · DOI
  35. Si, 2006, Continuous in vivo infusion of interferon-γ (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca−/− and Fancg−/− mice, Blood, 108, 4283, 10.1182/blood-2006-03-007997 · DOI
  36. Cattoglio, 2007, Hot spots of retroviral integration in human CD34+ hematopoietic cells, Blood, 110, 1770, 10.1182/blood-2007-01-068759 · DOI
  37. Dull, 1998, A third-generation lentivirus vector with a conditional packaging system, J Virol, 72, 8463, 10.1128/JVI.72.11.8463-8471.1998 · DOI · Paper page
  38. Schambach, 2006, Equal potency of γ-retroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells, Mol Ther, 13, 391, 10.1016/j.ymthe.2005.08.012 · DOI
  39. Schambach, 2006, Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression, Gene Ther, 13, 641, 10.1038/sj.gt.3302698 · DOI
  40. Crone, 1994, Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine, Cancer Res, 54, 6221
  41. Naldini, 1996, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, 272, 263, 10.1126/science.272.5259.263 · DOI · Paper page
  42. Geiger, 1998, Globin gene expression is reprogrammed in chimeras generated by injecting adult hematopoietic stem cells into mouse blastocysts, Cell, 93, 1055, 10.1016/S0092-8674(00)81210-6 · DOI
  43. Hanenberg, 1996, Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells, Nat Med, 2, 876, 10.1038/nm0896-876 · DOI
  44. Villella, 2005, Real-time PCR: an effective tool for measuring transduction efficiency in human hematopoietic progenitor cells, Mol Ther, 11, 483, 10.1016/j.ymthe.2004.10.017 · DOI
  45. Will, 2007, Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials, Mol Ther, 15, 782, 10.1038/sj.mt.6300083 · DOI

Cited by

See all 32

Metadata

Authors
Müller, L. U., Milsom, M. D., Kim, M.-O., Schambach, A., Schuesler, T., & Williams, D. A.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2008-06
Volume
16
Issue
6
Pages
1154-1160
ISSN
1525-0016
Cited by
32
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid lentiviral transduction preserves the engraftment potential of Fanca(−/−) hematopoietic stem cells. https://app.cochat.ai/papers/10.1038/mt.2008.67
The paper
Müller, L. U., Milsom, M. D., Kim, M.-O., Schambach, A., Schuesler, T., & Williams, D. A. (2008). Rapid lentiviral transduction preserves the engraftment potential of Fanca(−/−) hematopoietic stem cells. Molecular Therapy. https://doi.org/10.1038/mt.2008.67